The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.
about
Pulmonary toxicity in a rabbit model of stereotactic lung radiation therapy: efficacy of a radioprotector.Radioprotective agents for radiation therapy: future trends.Radiobiological modifiers in clinical radiation oncology: current reality and future potential.Emerging targets for radioprotection and radiosensitization in radiotherapy.Trial Watch: Radioimmunotherapy for oncological indications.Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update
P2860
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The addition of amifostine to ...... (RTOG) randomized trial 9801.
@en
type
label
The addition of amifostine to ...... (RTOG) randomized trial 9801.
@en
prefLabel
The addition of amifostine to ...... (RTOG) randomized trial 9801.
@en
P2093
P2860
P50
P1433
P1476
The addition of amifostine to ...... (RTOG) randomized trial 9801.
@en
P2093
Benjamin Movsas
Colum Smith
Corey Langer
Jeffrey D Bradley
Mark K Buyyounouski
Rebecca Paulus
Rita S Axelrod
Todd Wasserman
Yaacov Richard Lawrence
P2860
P304
P356
10.1016/J.LUNGCAN.2013.02.008
P577
2013-03-07T00:00:00Z